Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-09

Clinical Trial Update: Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)

View source ↗

Summary

This clinical trial update describes Project PENGUIN, a University of Missouri-Columbia study exploring phenotypic, epigenetic, and neurogenetic traits in rare …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Baker Gordon Syndrome, Rare Neurodevelopmental Conditions | Status: RECRUITING